No black box warning on record for Korlym

As of the latest FDA labeling reviewed, Korlym (MIFEPRISTONE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Korlym medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Adrenal insufficiency : Patients should be closely monitored for signs and symptoms of adrenal insufficiency ( 5.1 ). Hypokalemia : Hypokalemia should be corrected prior to treatment and monitored for during treatment ( 5.2 ). Vaginal bleeding and endometrial changes : Women may experience endometrial thickening or unexpected vaginal bleeding. Use with caution if patient

No black box warning on record for Korlym

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Adrenal insufficiency : Patients should be closely monitored for signs and symptoms of adrenal insufficiency ( 5.1 ). Hypokalemia : Hypokalemia should be corrected prior to treatment and monitored for during treatment ( 5.2 ). Vaginal bleeding and endometrial changes : Women may experience endometrial thickening or unexpected vaginal bleeding. Use with caution if patient

Korlym Black Box Warning

No black box warning on record for Korlym

Other warnings & precautions

Korlym Black Box Warning

No black box warning on record for Korlym

Other warnings & precautions